UK Biotechs Still Set On Cashing Out
Homegrown Global Player Yet To Take Root
Excluding the multinational majors AstraZeneca and GSK, the UK has yet to produce a truly successful scaled pharma company, despite having boasted several innovative start-ups. Whether that represents a negative, however, is a matter for debate.
